P. Méndez

发表

Molecular predictors of response to chemotherapy in lung cancer.

J. Mate, E. Felip, A. Ariza, 2004, Seminars in oncology.

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients.

M. Taron, M. Santarpia, M. Sánchez-Ronco, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.

Y. Roussos, C. Balañà, A. Ariza, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

O 6-methyl-guanine-DNA methyltransferase Methylation in Serum and Tumor DNA Predicts Response to 1 , 3-Bis ( 2-Chloroethyl )-1-Nitrosourea but not to Temozolamide Plus Cisplatin in Glioblastoma Multiforme 1

Y. Roussos, C. Balañà, A. Ariza, 2003 .

Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer.

Pedro Mendez, Jose Luis Mate, Rafael Rosell, 2005, Lung cancer.

Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression

R. Rosell, M. Taron, N. Reguart, 2009, PloS one.

Gene Expression as a Predictive Marker of Outcome in Stage IIB-IIIA-IIIB Non-Small Cell Lung Cancer After Induction Gemcitabine-Based Chemotherapy Followed By Resectional Surgery

E. Felip, R. Rosell, M. Taron, 2004, Clinical Cancer Research.

Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine

D. Mavroudis, I. Boukovinas, M. Taron, 2008, British Journal of Cancer.

Clinical significance of hypoxia-inducible factor-1a messenger RNA expression in locally advanced non-small-cell lung cancer after platinum agent and gemcitabine chemotherapy followed by surgery.

E. Felip, R. Rosell, M. Taron, 2005, Clinical lung cancer.

Serum DNA as a tool for cancer patient management.

C. Balañà, M. Taron, J. Ramírez, 2003, Roczniki Akademii Medycznej w Bialymstoku.

Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients.

C. García-Girón, R. Rosell, M. Taron, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Single Cell DNA Sequencing Identifies Combinatorial Mutation Patterns and Clonal Architecture in Myeloid Malignancies

E. Papaemmanuil, M. Carroll, R. Levine, 2019, Blood.

Squamous cell carcinoma of the head and neck in patients under 40 years of age.

W. Panje, P. Méndez, M. Maves, 1985, Archives of otolaryngology.

Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy.

J. Baselga, J. J. de la Cruz, J. Carles, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Mobile Genome Express (MGE): A comprehensive automatic genetic analyses pipeline with a mobile device

Jun-Hee Yoon, Thomas W Kim, Pedro Mendez, 2017, PloS one.

Systematic comparison of two whole-genome amplification methods for targeted next-generation sequencing using frozen and FFPE normal and cancer tissues

D. Jablons, Il-Jin Kim, P. Méndez, 2017, Scientific Reports.

Single cell mutation analysis of clonal evolution in myeloid malignancies

A. Abate, M. Carroll, R. Levine, 2020, Nature.

Genotypes That Predict Toxicity and Genotypes That Predict Efficacy of Anticancer Drugs

R. Rosell, M. Taron, P. Méndez, 2008 .

Comprehensive evaluation and validation of targeted next-generation sequencing performance in two clinical laboratories.

D. Jablons, Il-Jin Kim, P. Méndez, 2016, International journal of oncology.

Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomas

K. Jones, K. Jen, D. Jablons, 2016, Oncotarget.

Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer Patients

D. Mavroudis, V. Georgoulias, R. Rosell, 2008, PloS one.

Three-Gene Expression Signature Predicts Survival in Early-Stage Squamous Cell Carcinoma of the Lung

Marcin Skrzypski, Ewa Jassem, Witold Rzyman, 2008, Clinical Cancer Research.

Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients.

R. Rosell, Jia Wei, M. Taron, 2010, Lung cancer.

Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung.

J. Ramírez, P. Méndez, 2013, Translational lung cancer research.

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer.

E. Felip, R. Rosell, M. Taron, 2004, Human molecular genetics.

Fifth Educational Symposium of the Spanish Lung Cancer Group: report on the Molecular Biology Workshop.

R. Rosell, S. Simonetti, C. Rolfo, 2011, Lung cancer.

Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non–Small-Cell Lung Cancer Patients with EGFR Mutations

J. Mate, C. Sawyers, A. Ariza, 2011, Clinical Cancer Research.

The place of targeted therapies in the management of non-small cell bronchial carcinoma. Molecular markers as predictors of tumor response and survival in lung cancer.

R. Rosell, J. Ramírez, C. Camps, 2006, Revue des maladies respiratoires.

BRCA1: A Novel Prognostic Factor in Resected Non-Small-Cell Lung Cancer

J. Jassem, R. Rosell, E. Jassem, 2007, PloS one.

A modified host-cell reactivation assay to quantify DNA repair capacity in cryopreserved peripheral lymphocytes.

R. Rosell, M. Taron, P. Méndez, 2011, DNA repair.

Platinum resistance related to a functional NER pathway.

R. Rosell, M. Taron, P. Méndez, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Genitourinary tumors, non-prostate

S. J. Park, I. Tannock, S. Groshen, 2012 .

Single cell mutational profiling delineates clonal trajectories in myeloid malignancies

M. Carroll, R. Levine, A. Goldberg, 2020, bioRxiv.

XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression.

R. Rosell, F. Roila, Jia Wei, 2009, Clinical lung cancer.

Development of a robust DNA quality and quantity assessment qPCR assay for targeted next-generation sequencing library preparation

D. Jablons, Il-Jin Kim, P. Méndez, 2016, International journal of oncology.

O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.

Y. Roussos, C. Balañà, A. Ariza, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.